238 related articles for article (PubMed ID: 24518491)
1. Pi*Z heterozygous alpha-1 antitrypsin states accelerate parenchymal but not biliary cirrhosis.
Cacciottolo TM; Gelson WT; Maguire G; Davies SE; Griffiths WJ
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):412-7. PubMed ID: 24518491
[TBL] [Abstract][Full Text] [Related]
2. Association of α 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation.
Abu Rmilah A; Fencl R; Watt K; Krowka M; Wiesner R; Murray D; Nyberg S; Leise M
Transplantation; 2021 Jul; 105(7):1576-1584. PubMed ID: 32732616
[TBL] [Abstract][Full Text] [Related]
3. Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis.
Strnad P; Buch S; Hamesch K; Fischer J; Rosendahl J; Schmelz R; Brueckner S; Brosch M; Heimes CV; Woditsch V; Scholten D; Nischalke HD; Janciauskiene S; Mandorfer M; Trauner M; Way MJ; McQuillin A; Reichert MC; Krawczyk M; Casper M; Lammert F; Braun F; von Schönfels W; Hinz S; Burmeister G; Hellerbrand C; Teufel A; Feldman A; Schattenberg JM; Bantel H; Pathil A; Demir M; Kluwe J; Boettler T; Ridinger M; Wodarz N; Soyka M; Rietschel M; Kiefer F; Weber T; Marhenke S; Vogel A; Hinrichsen H; Canbay A; Schlattjan M; Sosnowsky K; Sarrazin C; von Felden J; Geier A; Deltenre P; Sipos B; Schafmayer C; Nothnagel M; Aigner E; Datz C; Stickel F; Morgan MY; Hampe J; Berg T; Trautwein C
Gut; 2019 Jun; 68(6):1099-1107. PubMed ID: 30068662
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of alpha-1-antitrypsin heterozygosity in children with chronic liver disease.
Campbell KM; Arya G; Ryckman FC; Alonso M; Tiao G; Balistreri WF; Bezerra JA
J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):99-103. PubMed ID: 17204961
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis.
Hodges JR; Millward-Sadler GH; Barbatis C; Wright R
N Engl J Med; 1981 Mar; 304(10):557-60. PubMed ID: 6969850
[TBL] [Abstract][Full Text] [Related]
6. [alpha 1-Antitrypsin phenotypes in patients with chronic liver diseases].
Pott G; Schneider M; van Husen N; von Bassewitz DB; Eberhardt G; Gerlach U
Z Gastroenterol; 1983 Jul; 21(7):318-23. PubMed ID: 6604375
[TBL] [Abstract][Full Text] [Related]
7. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
[TBL] [Abstract][Full Text] [Related]
8. Heterozygosity for the alpha-1-antitrypsin Z allele in cirrhosis is associated with more advanced disease.
Schaefer B; Mandorfer M; Viveiros A; Finkenstedt A; Ferenci P; Schneeberger S; Tilg H; Zoller H
Liver Transpl; 2018 Jun; 24(6):744-751. PubMed ID: 29573137
[TBL] [Abstract][Full Text] [Related]
9. Alpha-1-antitrypsin MZ phenotype and cryptogenic chronic liver disease in adults.
Vecchio FM; Fabiano A; Orsini G; Ragusa D; Massi G
Digestion; 1983; 27(2):100-4. PubMed ID: 6354808
[TBL] [Abstract][Full Text] [Related]
10. Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease.
Tang Y; Fickert P; Trauner M; Marcus N; Blomenkamp K; Teckman J
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G156-65. PubMed ID: 27102560
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic heteropolymerization of M and Z alpha-1-antitrypsin.
Laffranchi M; Elliston EL; Miranda E; Perez J; Ronzoni R; Jagger AM; Heyer-Chauhan N; Brantly ML; Fra A; Lomas DA; Irving JA
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32699193
[TBL] [Abstract][Full Text] [Related]
12. Hepatocytic globules in end-stage hepatic disease: relationship to alpha1-antitrypsin phenotype.
Iezzoni JC; Gaffey MJ; Stacy EK; Normansell DE
Am J Clin Pathol; 1997 Jun; 107(6):692-7. PubMed ID: 9169667
[TBL] [Abstract][Full Text] [Related]
13. Coronary artery disease and its risk factors in patients presenting for liver transplantation.
Gologorsky E; Pretto EA; Fukazawa K
J Clin Anesth; 2013 Dec; 25(8):618-23. PubMed ID: 23994032
[TBL] [Abstract][Full Text] [Related]
14. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study.
Regev A; Guaqueta C; Molina EG; Conrad A; Mishra V; Brantly ML; Torres M; De Medina M; Tzakis AG; Schiff ER
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S30-5. PubMed ID: 16819398
[TBL] [Abstract][Full Text] [Related]
15. Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.
Schneider CV; Hamesch K; Gross A; Mandorfer M; Moeller LS; Pereira V; Pons M; Kuca P; Reichert MC; Benini F; Burbaum B; Voss J; Gutberlet M; Woditsch V; Lindhauer C; Fromme M; Kümpers J; Bewersdorf L; Schaefer B; Eslam M; Bals R; Janciauskiene S; Carvão J; Neureiter D; Zhou B; Wöran K; Bantel H; Geier A; Dirrichs T; Stickel F; Teumer A; Verbeek J; Nevens F; Govaere O; Krawczyk M; Roskams T; Haybaeck J; Lurje G; Chorostowska-Wynimko J; Genesca J; Reiberger T; Lammert F; Krag A; George J; Anstee QM; Trauner M; Datz C; Gaisa NT; Denk H; Trautwein C; Aigner E; Strnad P;
Gastroenterology; 2020 Aug; 159(2):534-548.e11. PubMed ID: 32376409
[TBL] [Abstract][Full Text] [Related]
16. Both α-1-antitrypsin Z phenotypes and low caeruloplasmin levels are over-represented in alcohol and nonalcoholic fatty liver disease cirrhotic patients undergoing liver transplant in Ireland.
El-Rayah EA; Twomey PJ; Wallace EM; McCormick PA
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):364-367. PubMed ID: 29324588
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency.
Graziadei IW; Joseph JJ; Wiesner RH; Therneau TM; Batts KP; Porayko MK
Hepatology; 1998 Oct; 28(4):1058-63. PubMed ID: 9755243
[TBL] [Abstract][Full Text] [Related]
18. Alpha-1 antitrypsin deficiency in patients with chronic hepatitis.
Şımşek H; Pinar A; Altinbaş A; Alp A; Balaban YH; Büyükaşik Y; Özcebe O; Hasçelık G; Gedıkoğlu G; Tatar G
Turk J Gastroenterol; 2012; 23(5):569-73. PubMed ID: 23161303
[TBL] [Abstract][Full Text] [Related]
19. [Non-alcoholic fatty liver disease--new view].
Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
[TBL] [Abstract][Full Text] [Related]
20. [Genome-wide association studies in hepatology].
Weber S; Grünhage F; Hall R; Lammert F
Z Gastroenterol; 2010 Jan; 48(1):56-64. PubMed ID: 20072997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
